Posts

ESMO 2023 | Dr. Naidoo reviews perioperative immunotherapy modalities for operable Non-Small Cell Lung Cancer

ESMO 2023 | Dr. McCormack analyzes the impact of the INTERLACE trial on the treatment of locally advanced cervical cancer

ESMO 2023 | Dr. Spicer explains controversies in perioperative immunotherapy for patients with early-stage NSCLC

ESMO 2023 | Dr. Lorusso commented on the results of the DUO-E and KEYNOTE-A18 trials

ESMO 2023 |Dr. Passaro reviews the exploration of the Amivantamab combination regimen in the treatment of EGFR-mutated NSCLC

ESMO 2023 |Dr. Girard analyses PAPILLON: Opening new doors for first-line treatment of EGFR Exon 20 insertion-mutated advanced NSCLC